Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2025 May;23(5):132-140.
doi: 10.6004/jnccn.2025.0023.

NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025

Shaji K Kumar  1 , Natalie S Callander  2 , Kehinde Adekola  3 , Larry D Anderson  4 , Muhamed Baljevic  5 , Rachid Baz  6 , Erica Campagnaro  7 , Caitlin Costello  8 , Christopher D'Angelo  9 , Benjamin Derman  10 , Srinivas Devarakonda  11 , Noura Elsedawy  12 , Amandeep Godara  13 , Kelly Godby  14 , Jens Hillengass  15 , Leona Holmberg  16 , Myo Htut  17 , Carol Ann Huff  18 , Malin Hultcrantz  19 , Yubin Kang  20 , Sarah Larson  21 , Hans C Lee  22 , Michaela Liedtke  23 , Thomas Martin  24 , James Omel  25 , Timothy Robinson  26 , Aaron Rosenberg  27 , Mark A Schroeder  28 , Daniel Sherbenou  29 , Attaya Suvannasankha  30 , Jason Valent  31 , Asya Nina Varshavsky-Yanovsky  32 , Dan Vogl  33 , Emily Kovach  34 , Rashmi Kumar  34
Affiliations
Practice Guideline

NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025

Shaji K Kumar et al. J Natl Compr Canc Netw. 2025 May.

Abstract

The NCCN Guidelines for Multiple Myeloma (MM) provide recommendations for diagnosis, initial workup, treatment, follow-up, and supportive care for patients with MM. These NCCN Guidelines Insights highlight the important updates and changes specific to systemic therapy for patients with newly diagnosed as well as previously treated MM included in Version 1.2025 of the NCCN Guidelines for MM.

PubMed Disclaimer

References

Publication types

LinkOut - more resources